Halozyme Appoints Barbara Duncan to its Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 124.25 -0.29 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.54 | 52 Week High | $18.39 | |||
| Open | $124.54 | 52 Week Low | $6.96 | |||
| Day High | $124.60 | P/E | N/A | |||
| Day Low | $123.84 | EPS | $-0.58 | |||
| Volume | 41,376 | |||||
